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Edited by Lev KisselevAbstract In certain methanogenic archaea a new amino acid,
pyrrolysine (Pyl), is inserted at in-frame UAG codons in the
mRNAs of some methyltransferases. Pyl is directly acylated
onto a suppressor tRNAPyl by pyrrolysyl-tRNA synthetase
(PylRS). Due to the lack of a readily available Pyl source, we
looked for structural analogues that could be aminoacylated by
PylRS onto tRNAPyl. We report here the in vitro aminoacylation
of tRNAPyl by PylRS with two Pyl analogues: N-e-D-prolyl-L-
lysine (D-prolyl-lysine) and N-e-cyclopentyloxycarbonyl-L-lysine
(Cyc). Escherichia coli, transformed with the tRNAPyl and
PylRS genes, suppressed a lacZ amber mutant dependent on
the presence of D-prolyl-lysine or Cyc in the medium, implying
that the E. coli translation machinery is able to use Cyc-tRNAPyl
and D-prolyl-lysine-tRNAPyl as substrates during protein synthe-
sis. Furthermore, the formation of active b-galactosidase shows
that a specialized mRNA motif is not essential for stop-codon
recoding, unlike for selenocysteine incorporation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Aminoacyl-tRNA synthetase1. Introduction
In the Methanosarcinaceae, a family of methanogenic
archaea, the new amino acid pyrrolysine (Pyl) was shown to
be present in the mono-, di- and tri-methylamine methyltrans-
ferases (MtmB, MtbB and MttB) [1,2]. This new amino acid is
co-translationally inserted in response to an in-frame UAG
codon located in the corresponding mRNAs [3]. The insertion
of this amino acid relies on the presence of a speciﬁc suppressor
tRNA (tRNAPyl) [4] and the new class II aminoacyl-tRNA
synthetase, pyrrolysyl-tRNA synthetase (PylRS) speciﬁc only
for its substrates tRNAPyl and Pyl [5,6]. The mechanism of
Pyl-tRNAPyl insertion at UAG is unknown, however, it has
been proposed that a specialized pyrrolysine insertion element
(PYLIS) is present immediately downstream of the UAGwhichAbbreviations: Pyl, pyrrolysine; PylRS, pyrrolysyl-tRNA synethetase
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doi:10.1016/j.febslet.2006.11.028assists in the recoding event. Although putative secondary
structures have been identiﬁed, their role in recoding in vivo re-
mains uncertain [7,8].
Determination of the crystal structure of nativeMethanosar-
cina barkeri MtmB allowed the elucidation of the molecular
structure of this new amino acid. Analysis of the electron
density showed that pyrrolysine is a dipeptide composed of a
lysine modiﬁed at its e-N by a 4-methyl-pyrroline-5-carboxyl-
ate (Fig. 1) [1]. The electron density of the MtmB crystal struc-
ture indicated an anti relationship between the C4-methyl
group and the amide group, and it also suggested the presence
of a double bond between the nitrogen and C2 in the pyrroline
ring [1].
The detailed characterization of the novel synthetase PylRS
will rely on the production of practical amounts of Pyl. Based
on the ﬁrst reported structure of Pyl, for which the nature of
the C4 group was not ascertained, we initially undertook the
synthesis of the Pyl derivative bearing a hydroxyl group at the
C4 ring position. As the synthesis of this compound was unsuc-
cessful, we then devised a new synthetic route leading to the
more stable Pyl derivative bearing a methyl group at the C4
position (see supplemental data). The product obtained
(Fig. S1A, compound 8) allowed us to experimentally demon-
strate the direct attachment of Pyl to tRNAPyl by PylRS [6].
Pyl produced by a diﬀerent synthetic route [9], could be inserted
in the M. barkeri MtmB protein in an E. coli context [5].
However, in our hands this synthesis did not yield the desired
product.
Because these syntheses have a number of drawbacks, chief
among them the complexity of the synthesis, low yields and
high costs, we investigated the possibility of using simpler
and readily available Pyl structural analogues that would still
be substrates for PylRS and could be inserted into proteins
in E. coli.2. Materials and methods
2.1. General
Oligonucleotide synthesis and DNA sequencing were performed by
the Keck Foundation Biotechnology Resource Laboratory at Yale
University. Uniformly labeled sodium [32P] pyrophosphate [1–60 Ci/
mmol (1 Ci = 37 GBq)], [c-32P] ATP (6000 Ci/mmol) and [3H] serine
(28 Ci/mmol) were from Amersham Biosciences. Mouse raised mono-
clonal anti-E. coli b-galactosidase antibody was purchased from US
Biological. The pyrrolysine analogues purchase from Sigma were
L-lysine (Fig. 1, compound 1), N-e-methyl-L-lysine (Fig. 1, compound
2), N-e-formyl-L-lysine (Fig. 1, compound 3), N-e-acetyl-L-lysine
(Fig. 1, compound 4), and N-e-cyclopentyloxycarbonyl-L-lysine (Cyc)
(Fig. 1, compound 5). The pyrrolysine analogues N-e-D-prolyl-L-lysineblished by Elsevier B.V. All rights reserved.
Fig. 1. Pyrrolysine analogues tested as substrates for M. barkeri
PylRS: L-lysine (1); N-e-methyl-L-lysine (2); N-e-formyl-L-lysine (3);
N-e-acetyl-L-lysine (4); N-e-cyclopentyloxycarbonyl-L-lysine (Cyc) (5);
N-e-D-prolyl-L-lysine (D-prolyl-lysine) (6); N-e-L-prolyl-L-lysine (L-
prolyl-lysine) (7); N-e-(3-methyl-2,3-dihydro-pyrrol-2-yl)carbonyl-L-
lysine (PylE) (8); pyrrolysine (Pyl) (9). Compounds 1–3 and 7 could
not be activated by PylRS, and compound 4 only showed activity
slightly above background. Compounds Cyc (5), D-prolyl-lysine (6)
and PylE (8) were all activated by PylRS and could be charged onto
tRNAPyl in vitro.
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lysine) (Fig. 1, compound 7) and N-e-(3-methyl-2,3-dihydro-pyrrol-2-
yl)carbonyl-L-lysine (PylE) (Fig. 1, compound 8) were synthesized as
described in the supplemental data section. The M. barkeri Fusaro
tRNAPyl and PylRS were prepared as previously reported [6]. E. coli
strains XAC/A24 and FTP5822 were a gift from H. Nakano (Kyoto
University) and E. Murgola (University of Texas), respectively.
E. coli I-Z40 stain and of the pGFIB plasmid encoding E. coli suppres-
sor tRNALys were obtained from W. McClain (University of Wiscon-
sin-Madison).
2.2. Plasmids carrying pylS and pylT genes for in vivo expression
The M. barkeri pylS gene was PCR ampliﬁed and cloned into the
pCR2.1-TOPO. After sequence conﬁrmation, it was sub-cloned into
the pCBS2 vector (Ampr) under the control of the trpS promoter for
constitutive expression. The M. barkeri tRNAPyl gene was constructed
from two oligonucleotides inserted between the lpp promoter and the
rrn terminator of the chloramphenicol resistance-encoding pTECH
vector [10].2.3. ATP-[32P] PPi exchange with pyrrolysine analogues
The reactions were performed at 37 C, as described in [11], in
100 mM HEPES-NaOH (pH 7.2), 10 mM MgCl2, 50 mM KCl,
5 mM DTT, 2 mM KF, 2 mM ATP, 2 mM [32P] PPi (2 cpm/pmol),
200 nM of PylRS, and 500 lM of a pyrrolysine analogue (Fig. 1, com-
pounds 1–8) in a ﬁnal volume of 0.1 ml. [32P] ATP formation was
followed by speciﬁc absorption on acid-washed Norit [0.2 ml of a
1% suspension (wt/vol) of Norit in a solution of 0.4 M sodium pyro-
phosphate solution containing 15% (vol/vol) perchloric acid], ﬁltration
on Whatman GF/C ﬁlters, and washing with 15 ml of water and 5 ml
of ethanol. Cyc and D-prolyl-lysine concentration were varied from
300 lM to 3 mM for KM determination.
2.4. Aminoacylation assays and acid urea gel electrophoresis of
aminoacyl-tRNA
Aminoacylation assays were performed for 90 min at 37 C in
100 mM HEPES-NaOH (pH 7.2), 30 mM KCl, 15 mM MgCl2,
5 mM ATP, 5 mM DTT, 2 lM tRNAPyl transcript, 1.6 lM PylRS,
and 500 lM Cyc, D-prolyl-lysine or PylE. All reactions were started
by addition of the amino acid. The aminoacylation level was then vis-
ualized by acid urea gel electrophoresis and Northern blot as previ-
ously described [6].
2.5. Suppression of E. coli XAC/A24 lacI–lacZ nonsense mutation
E. coli strain XAC/A24 carries an inactivating mutation (Trp 220 to
UAG nonsense) in the lacI–lacZ fusion system [12]. The truncated pro-
tein resulting from premature termination of protein synthesis at the
in-frame stop codon is unable to degrade the chromogenic 2-nitro-
phenyl b-D-galactopyranoside (ONPG). E. coli strain XAC/A24 cells
were co-transformed by electroporation with plasmids carrying the
M. barkeri pylS (pCBS) and M. barkeri pylT (pTECH) genes. The
same strain carrying an E. coli amber suppressor tRNALys on a pGFIB
plasmid [13] was used as a positive control. Transformants were plated
on Luria–Bertani (LB) agar with both ampicillin and chloramphenicol
and incubated for 16 h at 37 C. Colonies were transferred to 5 ml of
LB liquid medium in the presence of antibiotics and cultured overnight
at 37 C. Fresh LB liquid medium was inoculated with the overnight
culture in the presence of antibiotics. Strains carrying the pylS and
pylT genes were further supplemented with either 10 mM Cyc,
10 mM D-prolyl-lysine, or no amino acid for control. Cells were culti-
vated at 37 C until A600 reached 0.6. The UAG suppression level was
determined by quantitative analysis of the b-galactosidase activity,
which was performed according to the standard procedure [14]. Values
are the average of triplicate measurements and are reported as the per-
centage of mutant enzyme activity relative to that of the wild type en-
zyme produced by the E. coli I-Z40 strain, which carries the lacI–lacZ
fusion with a wild type tryptophan codon in place of the UAG triplet.
2.6. Detection of LacI–LacZ fusion protein by immunoblot analysis
E. coli XAC/A24 strain carrying the plasmid copy ofM. barkeri pylS
and pylT genes was grown overnight in 5 ml of LB in the presence or
absence of 10 mM Cyc. The same strain carrying an E. coli amber
suppressor tRNALys on a pGFIB plasmid [13] was used as a positive
control. Cell free extracts were prepared, ﬁltered on a Microcon 50
(Millipore), concentrated in a speed-vac, and analyzed on a 4–20%
polyacrylamide/SDS gel (Biorad). The protein extracts were trans-
ferred onto PVDF membrane by using a Bio-Rad blotter. The mem-
brane was incubated with diﬀerent dilutions of the anti-E. coli
b-galactosidase antibodies (1:100–1:1000) for optimal detection. For
the immunoblot analysis, the colorimetric Opti-4CN substrate and
detection kit (Bio-Rad) was used (horseradish peroxidase conjugate).
2.7. Suppression of E. coli FTP5822 trpA nonsense mutation
E. coli strain FTP5822 carries an inactivating mutation in the trpA
gene (Gln 243 to UAG nonsense) [15] which results in tryptophan au-
xotrophy. Cells were co-transformed by electroporation with plasmids
carryingM. barkeri pylS (pCBS) andM. barkeri pylT (pTECH) genes.
Transformants were plated on LB agar with both ampicillin and chlo-
ramphenicol and incubated for 16 h at 37 C. Colonies were trans-
ferred to 5 ml of LB liquid medium in the presence of antibiotics
and cultured for 16 h at 37 C. Subsequently, cells were washed with
M9 minimal medium and used to inoculate 2 ml of M9 minimal
medium containing antibiotics and 10 mM Cyc or no amino acid as
a control. E. coli strain FTP5822 transformed with pGFIB plasmid
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was used as a positive control. Cells were incubated at 37 C. Bacterial
growth was followed by measuring cell density over time using a
Spectronic 20D+spectrophotometer (Thermo). Values are the average
of triplicate measurements.
Measurement of the tryptophan synthetase activity allowed a more
quantitative measurement of the suppression eﬃciency than growth
curves. Overnight cultures of E. coli FTP5822 in M9 minimal medium
were used to inoculate 5 ml of M9 minimal medium, as before, in the
presence or absence of 10 mM Cyc. All cultures were incubated at
37 C to late log phase, harvested by centrifugation, washed twice with
NaCl (0.9%), and resuspended in buﬀer A (0.05 M potassium phos-
phate (pH 7.0), 0.1 mg/ml of pyridoxal-5-phosphate, 10 mM 2-mercap-
toethanol). Cell extract was prepared [16], micro-dialyzed against
buﬀer A and used immediately for the assay. IGP was freshly prepared
as described [8]. Tryptophan synthetase was assayed in the IGP to Trp
conversion with [3H] serine (28.0 Ci/mmol) [17]. Enzymatic unit is
deﬁned as the amount producing 1 lmol of tryptophan/mg of protein,
and expressed as percentage of mutant enzyme activity relative to that
of the wild type TrpA in E. coli strain W3110.3. Results and discussion
3.1. Pyl analogues are activated and ligated onto tRNAPyl by
PylRS in vitro
Pyrrolysine is essentially a modiﬁed lysine. The crystal struc-
ture of theM. barkeriMtmB enzyme has shown that this novel
amino acid is the result of the coupling of a C-4 methyl pyrro-
lyine ring to the lysine e primary amine via an amide bond [1,9].
While pyrrolysine is the natural substrate of PylRS, lysine is not
recognized by the enzyme [6]. In an attempt to obtain a suitable
substrate for PylRS biochemical characterization and gain
insight on the contribution of the pyrrolyine ring to pyrrolysine
recognition by PylRS, we looked for commercially available or
easily synthesizable lysine analogues that would progres-
sively add components of the pyrrolyine ring (Fig. 1). We
then measured the ability of these analogues to promote
the PylRS catalyzed ATP-[32P] PPi exchange reaction. N-e-
methyl-L-lysine, N-e-formyl-L-lysine and N-e-L-prolyl-L-lysine
(L-prolyl-lysine) were not able to be activated by PylRS (data
not shown), and N-e-acetyl-L-lysine allowed measurement only
slightly above background (Fig. 2A). The N-e-cyclopentyl-
oxycarbonyl-L-lysine (Cyc) and N-e-D-prolyl-L-lysine (D-
prolyl-lysine) compounds were activated by PylRS, although
not as eﬃciently as the pyrrolysine enamine derivativeFig. 2. Activation and ligation onto tRNAPyl transcript of pyrrolysine an
pyrrolysine analogues: PylE (d), Cyc (j), L-prolyl-lysine (m), N-e-acetyl-L-
tRNAPyl transcript with Pyl analogues as visualized by acid urea gel electroph
tRNAPyl aminoacylated with D-prolyl-lysine (L3), tRNAPyl aminoacylated w
ATP-[32P] PPi exchange reaction and tRNA
Pyl transcript aminoacylation witN-e-(3-methyl-2,3-dihydro-pyrrol)oxycarbonyl-L-lysine (PylE)
(Fig. 2A). Determination of the KM value in ATP-[
32P] PPi
exchange reaction for Cyc (KM 670 lM) and D-prolyl-lysine
(KM 500 lM) showed a loss in apparent aﬃnity for PylRS of
about 10-fold when compared to the published value for pyrr-
olysine (KM 53 lM in [5]). In addition to demonstrating amino
acid activation, the analogues Cyc, D-prolyl-lysine and PylE
were successfully ligated onto tRNAPyl by PylRS in vitro
(Fig. 2B).
Interestingly, while D-prolyl-lysine was a substrate for PylRS
the analog L-prolyl-lysine was not, indicating the crucial
importance of the pyrrolysine ring C-5 stereocenter for recog-
nition by the synthetase. The importance of C-5 (R) conforma-
tion has been suggested before [6]. Our attempt at synthesizing
pyrrolysine yielded a mixture of diastereoisomers in which the
stereoconformation of the carbon bearing the amide group
was not ﬁxed (see supplemental data). Upon analysis of the
amino acid attached by the PylRS to tRNAPyl in vitro, we
saw that only one of the diastereoisomers was selected by the
synthetase [6]. The pyrroline ring nitrogen does not make a
strong contribution to PylRS binding since its presence in
D-prolyl-lysine only resulted in a small improvement in aﬃnity
over that of Cyc, but the incorrect positioning of the nitrogen
in the PylRS active site appears to be detrimental to amino
acid activation. The molecular basis for the rejection of the
L-prolyl-lysine isomer may become apparent when the struc-
tural analysis of the amino acid binding site of PylRS becomes
available [18]. The need to reject a Pyl isomer with an incorrect
ring stereoconformation is essential as the UAG-coded posi-
tion for Pyl is in the active site of the methyltransferase
enzymes and presumably essential for enzyme activity [1].
One possible source of a pyrrolysine isomer with the incor-
rect conformation may be from the coupling of a member of
the proline biosynthetic pathway to lysine, as proline and Pyl
may share an intermediate metabolite with some structural
homology. Although nothing is known on Pyl biosynthesis it
has been hypothesized that Pyl might result from the coupling
of the D-methyl-D1-pyrroline-5-carboxylate ring to lysine by an
amino acid ligase that remains to be identiﬁed [19]. Cells con-
tain signiﬁcant concentrations of L-D1-pyrroline-5-carboxyl-
ate, an intermediate metabolite in proline biosynthesis and
close structural analogue to D-methyl-D1-pyrroline-5-carboxyl-
ate. The erroneous coupling of the proline precursor to lysinealogues by M. barkeri PylRS. (A) Time course for the activation of
lysine (r), no amino acid control (). (B) In vitro aminoacylation of
oresis: tRNAPyl transcript (L1), tRNAPyl aminoacylated with Cyc (L2),
ith PylE (L4), and aminoacylation reaction with no amino acid (L5).
h the pyrrolysine analogues were conducted as described in Section 2.
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formation at the ring level, and consequently interfere with
methyltransferase activity.
3.2. Insertion of Pyl analogues into proteins in E. coli
Since Cyc and D-prolyl-lysine were suitable substrates for
PylRS in vitro, we then tested whether they would be sub-
strates in an in vivo context and whether they would be incor-
porated into proteins. Previous experiments have shown that
when Pyl is added to the growth media of an E. coli strain con-
taining plasmids bearing pylS, pylT, and mtmB genes from M.
barkeri, Pyl can be inserted into MtmB proteins at UAG, indi-
cating that the bacterial translation machinery can use Pyl-
tRNAPyl [5]. In order to be able to visualize and quantify the
level of suppression obtained upon insertion of the Pyl ana-
logues we used a b-galactosidase based reporter system. The
E. coli XAC strains in which a UAG in-frame codon has been
inserted in the lacI part of a lacI–lacZ fusion gene have been
extensively used to assess sequence-function relationships of
a wide range of tRNA molecules by quantifying the b-galacto-
sidase activity resulting from suppression of the amber stop co-
don [20–22]. We transformed the E. coli XAC/A24 strain with
plasmids carrying pylS and pylT genes. The b-galactosidase
activity could only be detected when the transformant cells
were grown in LB containing either Cyc or D-prolyl-lysine,
indicating that the PylS/tRNAPyl pair is truly orthogonal in
E. coli and that the Pyl analogues are inserted in the LacI–
LacZ fusion protein (Fig. 3A). The b-galactosidase activity
in cells grown with the Pyl analogues was compared to that
from either an E. coli strain containing in its genome a wild
type copy of the lacI–lacZ fusion gene or from the E. coli
XAC/A24 strain transformed with a plasmid carrying an
E. coli amber suppressor tRNALys. The amber suppressor
tRNALys allowed 38% read-through eﬃciency as previously
reported [13], and the suppression eﬃciency in cells grown
on Cyc and D-prolyl-lysine were 25% and 18%, respectively
(Fig. 3A). Interestingly, D-prolyl-lysine (KM 500 lM) was aFig. 3. Incorporation of Cyc and D-prolyl-lysine into b-galactosidase. (A) b-
the E. coli I-Z40 strain, which carries the lacI–lacZ fusion with a wild type
carrying lacI–lacZ with Trp220 to UAG mutation transformed with E. coli s
barkeri pylS and pylT grown in presence of either 10 mM Cyc (L3) of 10 m
transformed with pylT and empty pCBS2 vector (L6). (B) In vivo aminoacy
extracted from E. coli XAC/A24 strain transformed with M. barkeri pylS a
Immunoblot of full-length LacI–LacZ fusion protein. Total protein extract
(L2) and from E. coli XAC/A24 strain transformed with M. barkeri pylS anmoderately better substrate than Cyc (KM 670 lM) for amino
acid activation by PylRS in vitro, yet the addition of D-prolyl-
lysine in the growth medium resulted in slightly lower suppres-
sion eﬃciency relative to growth on Cyc. This suggests either a
more limited level of cellular uptake of D-prolyl-lysine or cellu-
lar degradation.
In addition to quantifying LacI–LacZ activity, we also di-
rectly established that UAG read-through in lacI–lacZ mRNA
was dependent on Cyc using an immunoblot analysis. This
showed the presence of a full length 150 kDa LacI–LacZ pro-
tein only in cells grown in the presence of Cyc, implying the
incorporation of the Pyl analogue at the suppression site with-
in lacI (Fig. 3B). Finally, we analyzed the in vivo charging level
of tRNAPyl using the acid gel electrophoresis method. While
tRNAPyl extracted from cells grown in the presence of Cyc
was signiﬁcantly aminoacylated, it was only present in a deacy-
lated form when Cyc was absent from the culture media
(Fig. 3C). Combined, this evidence indicates PylRS is speciﬁ-
cally acylating tRNAPyl with the Pyl analogs in vivo, and the
E. coli translation machinery is able to use this charged tRNA
in protein synthesis at levels comparable to other amber sup-
pressor aminoacyl-tRNAs.
In order to see whether Cyc insertion is being inﬂuenced by
the particular context in which the UAG codon is placed in
lacI–lacZ, we investigated whether the Pyl analogue could be
incorporated at a similar level in another E. coli protein.
Because extensive analysis of E. coli trpA mutant strains have
been conducted previously [15], and used as a powerful tool to
screen libraries of mutant tRNAs [23], we chose to use this sys-
tem as a reporter for Cyc incorporation. The E. coli strain
FTP5822 carries an inactivating mutation in the trpA gene
(Gln 243 to UAG nonsense), which results in a tryptophan
auxotrophy phenotype due to the organism’s inability to syn-
thesize this amino acid. This phenotype can be rescued either
when the cells are grown on an exogenic source of tryptophan
or when provided with a suitable suppressor tRNA. We trans-
formed the E. coli FTP5822 strain with plasmids carrying theGalactosidase activity catalyzed by the wild type enzyme produced by
tryptophan codon in place of the UAG triplet (L1), E. coli XAC/A24
uppressor tRNALys (L2), E. coli XAC/A24 strain transformed with M.
M D-prolyl-lysine (L4), no amino acid (L5), E. coli XAC/A24 strain
lation of tRNAPyl measured by acid gel electrophoresis. Total tRNA
nd pylT grown in presence (L3) or absence (L5) of 10 mM Cyc. (C)
from E. coli XAC/A24 strain transformed E. coli suppressor tRNALys
d pylT grown in presence (L3) or absence (L5) of 10 mM Cyc.
Fig. 4. Incorporation of Cyc and D-prolyl-lysine into tryptophan synthase. (A) Growth curve in M9 minimal media of E. coli FTP5822 strain
transformed with E. coli suppressor tRNALys (j), E. coli FTP5822 strain transformed with M. barkeri pylS and pylT grown in presence (d) or
absence (s) of 10 mM Cyc, E. coli FTP5822 strain transformed with either M. barkeri pylS (h) or M. barkeri pylT (n) and grown in presence of
10 mM Cyc. (B) In vivo aminoacylation of tRNAPyl as judged by acid gel electrophoresis. Total tRNA extracted from E. coli FTP5822 strain
transformed with M. barkeri pylS and pylT grown in presence (L1) or absence (L2) of 10 mM Cyc.
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the presence or absence of Cyc. The presence of the Pyl
analogue in the culture media restored bacterial growth, imply-
ing that a functional full-length tryptophan synthase had been
made (Fig. 4A). This was conﬁrmed by assaying tryptophan
synthase activity in cell free extracts of the E. coli grown in
presence of Cyc (2.6 U/mg, 16% of wild type activity). To com-
pare suppression activity, E. coli FTP5822 strain was also
transformed with the amber suppressor tRNALys and trypto-
phan synthase activity was measured (5.5 U/mg, 33% of wild
type activity). As with the lacI–lacZ read-through system,
tRNAPyl suppression was reduced relative to the suppressor
tRNALys, but still signiﬁcant. Analysis of the in vivo charging
level of tRNAPyl by the acid gel electrophoresis method
showed aminoacylation of tRNAPyl only when cells were
grown in presence of Cyc (Fig. 4B).
Previous studies of pyrrolysine insertion at UAG in E. coli
examined read-through in the mtmB gene which contains the
PYLIS element structure [5]. Here, we show that tRNAPyl
charged with D-prolyl-lysine and Cyc can be inserted at
UAG in both lacZ and trpA mRNA which presumably lack
any PYLIS element. These results establish that a PYLIS
element is not essential for signaling pyrrolysine insertion at
UAG. This is in contrast to selenocysteine insertion, which is
dependent on the presence of a selenocysteine insertion
element (SECIS). It is possible the PYLIS, while not absolutely
required, is important for enhancing the suppression level in
the methyltransferase gene.
3.3. Conclusions and perspectives
We identiﬁed two Pyl analogues, the commercially available
N-e-cyclopentyloxycarbonyl-L-lysine (Cyc) and N-e-D-prolyl-
L-lysine (D-prolyl-lysine) which is easily synthesized, that can
circumvent the lack of a reliable and cheap source of synthetic
Pyl for both in vitro and in vivo study of PylRS. By doing so,
we also established the essentiality of the pyrroline ring stereo-
chemistry, thus gaining some preliminary insight on the stru-
cture–activity relationships for Pyl recognition by PylRS.
Determination of the chemical pathway to Pyl and the genes
responsible for Pyl biosynthesis will allow the future produc-tion of the Pyl required for active site characterization of
PylRS. Furthermore, we establish that the PLYIS element is
not essential for pyrrolysine insertion at UAG codons, but raise
the possibility that PYLIS may enhance read-through levels.
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